Pulmonary arterial hypertension diagnosis and therapy

Oral Presentation
Chairs: P. E. Postmus (Amsterdam, The Netherlands), H. Matthys (Freiburg, Germany)

Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension S. A. van Wolferen, T. J. Marcus, A. Boonstra, P. E. Postmus, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
Sustained efficacy with the selective endothelin-A receptor antagonist, sitaxsentan, after two years of therapy in patients with pulmonary arterial hypertension D. Langleben, A. M. Hirsch, E. Shalit, L. Lesenko, R. J. Barst (Montreal, Canada; New York, United States Of America)
Long-term safety and tolerance of ambrisentan in patients with pulmonary arterial hypertension H. Olschewski, and the Ambrisentan in PAH Study Group (Graz, Austria)
Effects of phosphodiesterase type 5 inhibitor on pulmonary hemodynamics in the patients with high altitude pulmonary hypertension (results of 12 week randomized, blind, placebo-controlled study) B. K. Kojonazarov, T. A. Amatov, T. M. Sooronbaev, M. M. Mirrakhimov, N. W. Morrell, M. R. Wilkin, A. A. Aldashev (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
Long-term effects of bosentan on the heart and pulmonary hemodynamics in pulmonary arterial hypertension, a comparison study with epoprostenol S. A. van Wolferen, A. Vonk-Noordegraaf, A. Boonstra, P. E. Postmus (Amsterdam, Netherlands)
Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment A. A. Aldashev, B. K. Kojonazarov, M. M. Mirrakhimov, N. W. Morrell, M. R. Wilkins (Bishkek, Kyrgyzstan; London, United Kingdom)
Increased body weight and reduced vital capacity correlate with augmentation of pulmonary hypertension during intermittent hypoxia at an altitude of 3800 m according to five years‘ follow up A. S. Sarybaev, A. M. Maripov, A. C. Akunov, H. Le Roux, T. Kadyrov (Bishkek, Kyrgyzstan)
Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis V. Cottin, H. Nunes, P. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J. Cordier and the GERMOP (Lyon, Bobigny, Paris, Saint-Etienne, France)